You Get Your Digital Policy and Procedures Manual
PLUS
We can edit, print, assemble, and ship a physical binder to you!
Good news!
You will be getting a single digital file that contains more than 150 pages of policy and procedure documents for point of care testing for a CLIA waived lab.
In addition to the digital file, we'll print, assemble, and ship a physical binder to you!
INTRODUCING
The P&P Binder Digital File and Printed For you
Turn off the voice in your head that is telling you it is on your list of things to do. Now, it will be DONE!
Over 150 pages in this comprehensive resource.
Don't waste your time grinding through all of this when it's already done for you.
Exposure control plan
OSHA, HIPAA, and other checklists.
Workflow GAP analysis
P&P for handling controls, operational duties, receiving orders, and more.
Training documents for you and your staff
Transportation documents
With this purchase, you will receive a digital file that you can edit in the future if ever needed and a physical binder that will have policies and procedures in it for a point of care testing program. Whether you're already testing or you are planning on testing, this binder is being created to make your life easier. Way easier.
Created by an independent pharmacist for independent pharmacists.
Meet Dr. Kristin Tallent
Hello there! Opening a CLIA Laboratory has literally transformed my life. I’ve experienced firsthand what it feels like to transition from dispensing medications to implementing profit generating clinical services as a pharmacist. More than anything else, I want to share that with you.
If you’re a pharmacist, you owe it to yourself to at least take a leap to see what your career could look like providing much needed testing services to your community. To experience the shift in pharmacy and be part of the innovative pharmacists forging ahead to pave the way for our profession and pharmacy industry.
I look forward to being an integral part in your shift into clinical services.
In health and a whole lot of happiness,
Dr. Kristin Tallent, PharmD, CEO Collaborative Therapeutics
